Zemaira is an alpha1 -proteinase inhibitor (A1 -PI) indicated for chronic augmentation and maintenance therapy in adults with A1 -PI deficiency and clinical evidence of emphysema.
Alpha1 antitrypsin (A1AT) deficiency, or Alpha-1 for short, is a hereditary and progressive condition that affects your lungs. It’s passed down from parent to child through their genes.
Zemaira was proven in clinical trials to raise and maintain levels of the Alpha-1 protein.
Number of yearly treatments: 4
In clinical studies, the following adverse reactions were reported in at least 5% of subjects receiving Zemaira: headache, sinusitis, upper respiratory infection, bronchitis, fatigue, increased cough, fever, injection-site bleeding, nasal symptoms, sore throat, and swelled blood vessels.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Zemaira website.
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.